Towards Healthcare
Retinitis Pigmentosa Market
Updated Date: 01 November 2025   |   Report Code: 5114
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

Retinitis Pigmentosa Market Patient-Centered Care Models and Strategies

According to market projections, the retinitis pigmentosa sector is expected to grow from USD 14.89 billion in 2024 to USD 27.17 billion by 2034, reflecting a CAGR of 6.2%. In 2023, Autosomal Recessive RP dominated with 65% market share, but gene therapy is gaining traction at 23%, bringing new hope. North America leads the market, yet Asia Pacific is the fastest-growing region, signaling a potential shift in the landscape for Retinitis Pigmentosa treatment.

Last Updated : 01 November 2025 Category: Therapeutic Area Insight Code: 5114 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Retinitis Pigmentosa Market Assessment

  • Overview
  • Global Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Autosomal Dominant RP
    • Autosomal Recessive RP
    • X-linked RP
  • Global Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
    • Vit A Supplements
    • Gene Therapy
    • Vit A Supplements
    • Gene Therapy
    • Retinal Implants
    • Low Vision Aids
    • Surgery
    • Others
  • Global Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa

North America Retinitis Pigmentosa Market Assessment

  • Overview
  • North America  Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Autosomal Dominant RP
    • Autosomal Recessive RP
    • X-linked RP
  • North America Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
    • Vit A Supplements
    • Gene Therapy
    • Vit A Supplements
    • Gene Therapy
    • Retinal Implants
    • Low Vision Aids
    • Surgery
    • Others

Europe Retinitis Pigmentosa Market Assessment

  • Overview
  • Europe Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Autosomal Dominant RP
    • Autosomal Recessive RP
    • X-linked RP
  • Europe Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
    • Vit A Supplements
    • Gene Therapy
    • Vit A Supplements
    • Gene Therapy
    • Retinal Implants
    • Low Vision Aids
    • Surgery
    • Others

Asia Pacific Retinitis Pigmentosa Market Assessment

  • Overview
  • Asia Pacific Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Autosomal Dominant RP
    • Autosomal Recessive RP
    • X-linked RP
  • Asia Pacific Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
    • Vit A Supplements
    • Gene Therapy
    • Vit A Supplements
    • Gene Therapy
    • Retinal Implants
    • Low Vision Aids
    • Surgery
    • Others

Latin America Retinitis Pigmentosa Market Assessment

  • Overview
  • Latin America Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Autosomal Dominant RP
    • Autosomal Recessive RP
    • X-linked RP
  • Latin America Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
    • Vit A Supplements
    • Gene Therapy
    • Vit A Supplements
    • Gene Therapy
    • Retinal Implants
    • Low Vision Aids
    • Surgery
    • Others

Middle East and Africa Retinitis Pigmentosa Market Assessment

  • Overview
  • Middle East and Africa Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
    • Autosomal Dominant RP
    • Autosomal Recessive RP
    • X-linked RP
  • Middle East and Africa Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
    • Vit A Supplements
    • Gene Therapy
    • Vit A Supplements
    • Gene Therapy
    • Retinal Implants
    • Low Vision Aids
    • Surgery
    • Others

Company Profiles

  • Novartis
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Roche (Spark Therapeutics Inc)
  • MeiraDx
  • Astellas Pharma Inc.
  • Clino Corporation
  • Gensight Biologics
  • InFlectis BioScience
  • Bausch Health Companies Inc.
  • Adverum Biotechnologies
  • ReGenx Biosciences

Conclusion & Recommendations

FAQ's

Answer : Retinitis Pigmentosa (RP) is a genetic disorder affecting the retina, leading to the gradual loss of photoreceptor cells. Symptoms include decreased night and peripheral vision, progressing to tunnel vision, and potential blindness.

Answer : Creating innovative retinitis pigmentosa treatments, like gene therapy and stem cell therapy, is complex and expensive.

Answer : The North American region leads the retinitis pigmentosa market.
Any Questions

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar